The relation between QT interval and T-wave variables in hypertensive patients

Journal of Pharmacy and Bioallied Sciences

Volumn 3, Issue 3, 2011, Pages 339-344

  Mozos, Ioana ^a   Serban, Corina ^a  

^a Department of Pathophysiology   (India)

Author keywords

Hypertension; left ventricular hypertrophy; QT interval; Tpeak Tend interval

Indexed keywords

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE CORRECTED QTII; HEART RATE CORRECTED QTMAX; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN QT INTERVAL; MEAN T WAVE AMPLITUDE; MEAN T WAVE DURATION; MEAN TPEAK TEND INTERVAL; PRIORITY JOURNAL; QT DISPERSION; QT INTERVAL; QT INTERVAL IN LEAD DII; QT INTERVAL MAXIMUM DURATION; QT PROLONGATION; SENSITIVITY AND SPECIFICITY; T WAVE; T WAVE AMPLITUDE; T WAVE DURATION; TPEAK TEND INTERVAL;

EID: 80052743025     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.84433     Document Type: Conference Paper

References (39)

1. Rautaharju PM, Surawicz B, Gettes LS. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: Part IV: The ST segment, T and U waves, and the QT interval: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. J Am Coll Cardiol 2009;53:982-91
2. Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP, Lauer MS, et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. J Am Coll Cardiol 2008;52:1179-99
3. Gussack I, Antzelevitch C. Electrical Diseases of the Heart. Genetics, Mechanisms, Treatment, Prevention. Springer: London Limited. Verlag; 2008.
4. Zabel M, Portnoy S, Franz MR. Electrocardiographic indices of dispersion of ventricular repolarization: An isolated heart validation study. J Am Coll Cardiol 1995;25:746-52
5. Malik M, Batchvarov V. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 2000;36:1749-66.
6. Celi A. QT dispersion: Time for a revival? Intern Emerg Med 2006;1:262-3.
7. Mozos I, Hancu M, Jost N, Cristescu A. Multipolar QRST isointegral maps and QT dispersion in old myocardial infarction. Acta Physiol Hung 2010;97:11-21.
8. Zhao Z, Yuan Z, Ji Y, Wu Y, Qi Y. Left ventricular hypertrophy amplifies the QT, and Tp-e intervals and the Tp-e/QT ratio of left chest ECG. J Biomed Res 2010;24:69-72
9. Gupta P, Patel C, Patel H, Narayanaswamy S, Malhotra B, Geen JT, et al. Tp-e/QT ratio as an index of arrhythmogenesis. J Electrocardiol 2008;41:567-74.
10. Mozos I, Costea C. The QT interval and left ventricular hypertrophy in essential hypertension. In: Sobieszczanska M, Jagielski J, Macfarlane PW, editors. Electrocardiology 2009. Proceedings of the 36th International Congress on Electrocardiology, Wroclaw, Poland: JAKS Publishing Company; 2010. p. 203-9.
11. Fish JM, Di Diego JM, Nesterenko VV, Antzelevitch C. Epicardial activation of left ventricular wall prolongs QT interval and transmural dispersion of repolarization: Implications for biventricular pacing. Circulation 2004;109:2136-42 (Pubitemid 38620224)
12. Mozos I, Costea C, Serban C, Susan L. Factors associated with a prolonged QT interval in liver cirrhosis patients. J Electrocardiol 2011;44:105-8.
13. Mozos I, Hancu M, Cristescu A. Ventricular arrhythmia risk in elderly heart failure patients. Rev Glob Med Healthcare Res 2010;1:18-29.
14. Kunavarapu C, Bloomfield D. Role of noninvasive studies in risk stratification for sudden cardiac death. Clin Cardiol 2004;27:192-7. (Pubitemid 38451152)
15. Baguet JP, Erdine S, Mallion JM. Hypertension and arrhythmia. European Society of Hypertension Scientific Newsletter: Update Hypertens Manag 2005;6:24.
16. Mancia G, De Baker G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. Guidelines for the management of arterial hypertension. Eur Heart J 2007;28:1462-536.
17. Turrini P, Corrado D, Basso C, Nava A, Bauce B, Thiene G. Dispersion of Ventricular Depolarisation-Repolarisation. Circulation 2001;103:3075-80.
18. Bazett HC. An analysis of the time-relations of the electrocardiogram. Heart 1920;7:353-70.
19. Jain H, Avasthi R. Correlation between dipsersion of repolarization (QT dispersion) and ventricular ectopic beat frequency in patients with acute myocardial infarction: A marker for risk of arrhythmogenesis? Int J Cardiol 2004;93:69-73. (Pubitemid 38068512)
20. Ibanez A, Ferrero Jr. The ECG T-wave duration as an index of dispersion of ventricular repolarization: Insights from simulations. Comput Cardiol 2006;33:793-6.
21. Hevia JC, Antzelevitch C, Tornés Bárzaga F, Sanchez MD, Balea FD, Molina RZ, et al. Tpeak-Tend and Tpeak-Tend Dispersion as Risk Factors for Ventricular Tachycardia/Ventricular Fibrillation in Patients With the Brugada Syndrome. J Am Coll Cardiol 2006;47:1828-34.
22. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography. J Am Soc Echocardiogr 2005;18:1440-63.
23. Romhilt DW, Estes EH Jr. A point-score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J 1968;75:752-8.
24. Sokolov M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949;37:161-86.
25. Casale PN, Devereux RB, Kligfield P, Eisenberg RR, Miller DH, Chaudhary BS, et al. Electrocardiographic detection of left ventricular hypertrophy: Development and prospective validation of improved criteria. J Am Coll Cardiol 1985;6:572-80. (Pubitemid 16219234)
26. Oikarinen L, Nieminen MS, Viitasalo M, Toivonen L, Jern S, Dahlof B, et al. QRS Duration and QT Interval Predict Mortality in Hypertensive Patients with Left Ventricular Hypertrophy. The Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 2004;43:1029-34.
27. Hancock EW, Deal BJ, Mirvis DM, Okin P, Kligfield P, Gettes LS. AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part V: Electrocardiogram changes associated with cardiac chamber hypertrophy. Circulation 2009;19:e251-61.
28. Xu X, Rials SJ, Wu Y, Salata JJ, Liu T, Bharucha DB, et al. Left ventricular hypertrophy decreases slowly but not rapidly activating delayed rectifier potassium currents of epicardial and endocardial myocytes in rabbits. Circulation 2001;103:1585-90. (Pubitemid 32226269)
29. Kanters JK, Haarmark C, Vedel-Larsen E, Andersen MP, Graff C, Struijk JJ, et al. Tpeak Tend interval in long QT syndrome. J Electrocardiol 2008;41:603-8.
30. Wolk R, Mazurek T, Lusawa T, Wasek W, Rezler J. Left ventricular hypertrophy increases transepicardial dispersion of repolarisation in hypertensive patients: A differential effect on QTpeak and QTend dispersion. Eur J Clin Invest 2001;31:563-9. (Pubitemid 32642885)
31. Kumar R, Fisher M, Macfarlane PW. Diabetes and the QT interval: Time for debate. Br J Diabetes Vasc Dis 2004;4:146-50. (Pubitemid 38967707)
32. Crouch MA, Limon L, Cassano AT. Clinical relevance and management of drug-related QT interval prolongation. Pharmacotherapy 2003;23:881-908. (Pubitemid 36875672)
33. Schutte D, Obel WP. Dangerous and life-threatening drugs-practical lessons from the long QT syndrome. Cardiovasc J S Afr 2002;13:54-61. (Pubitemid 34742290)
34. Sohaib SM, Papacosta O, Morris R, Macfarlane PW, Whincup PH. Length of the QT interval: Determinants and prognostic implications in a population-based prospective study of older men. J Electrocardiol 2008;41:704-10.
35. Mozos I, Serban C, Costea C. The renal function and the QT interval in hypertensive patients. Rom Rev Lab Med 2010;2/4(18):36.
36. Mozos I, Costea C. Serum cholesterol, triglycerides and the QT interval in hypertensive patients. Atheroscler Suppl 2010;2:132.
37. Funada A, Hayashi K, Ino H, Fujino N, Uchiyama K, Sakata K, et al. Assessment of QT intervals and prevalence of short QT syndome in Japan. Clin Cardiol 2008;31:270-4. (Pubitemid 351961238)
38. Dias da Silva VJ, Ferreira Neto E, Salgado HC, Fazan R Jr. Chronic converting enzyme inhibition normalizes QT interval in aging rats. Braz J Med Biol Res 2002;35:1025-31. (Pubitemid 35452882)
39. Bennett MT, Gula LJ, Klein GJ, Skanes AC, Yee R, Chattha I, et al. Do beta-blockers affect non corrected QT interval in type 1 long QT syndrome? Circulation 2009;120:S653.